cyclic heptapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-12-13. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan-2 is frequently confused with afamelanotide, a linear analogue authorised in the European Union for erythropoietic protoporphyria. The two compounds differ in chain length, ring structure and receptor selectivity, so findings for one cannot be transferred directly to the other. Published controlled human data on melanotan-2 remain sparse, and much of what circulates online derives from small studies or unpublished reports. Questions about effect size, dose-response behaviour and long-term safety therefore remain unresolved.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence incorporates a lactam bridge that constrains the peptide into a ring, which increases resistance to enzymatic breakdown relative to the natural hormone. Researchers at the University of Arizona synthesised the compound in the late 1980s and early 1990s while studying pigmentation pathways. It has never received marketing approval from any national medicines regulator. In the scientific literature it is usually described as a laboratory research reagent rather than a therapeutic product.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated or oxidised impurities. Mass spectrometry, most often coupled to liquid chromatography, confirms molecular mass and detects substitutions that chromatography alone may miss. Amino acid analysis and peptide mapping supply additional structural evidence, while nuclear magnetic resonance is reserved for full structural confirmation. Laboratories that examine samples sold online report wide variation in actual content, with some vials containing little or none of the labelled material.
Melanotan-2 appears on the World Anti-Doping Agency prohibited list within the peptide hormone class, and several national regulators treat it as an unapproved prescription substance. Some countries restrict importation or sale for personal use. Because the compound is widely traded as a research chemical, the practical legal picture differs between jurisdictions and shifts over time. Human safety data covering long periods are limited, and whether repeated pigmentation changes carry any lasting risk to melanocytes remains an open question.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Alpha-MSH analogue with a lactam ring |
| Molecular formula | C50H69N15O9 | Commonly cited value for the neutral peptide |
| Molecular weight | 1024.18 g/mol | Calculated for the free molecule |
| Appearance | White to off-white powder | Typically supplied as a lyophilised solid |
| Solubility | Soluble in water, DMSO and ethanol | Dissolution in pure water is often slow |
Outside regulated medicine, melanotan II circulates through online vendors as a research chemical, often marketed for tanning. Products sold this way vary widely in purity, concentration, and labeling accuracy, and independent testing has documented discrepancies. Published reports describe both pigment effects and adverse reactions, including nausea, flushing, and darkening of existing moles. Long-term safety data are sparse, and no large controlled trial has established a risk profile. Questions about cumulative effects on melanocytes remain unresolved in the literature.
Melanotan II is a synthetic peptide analog modeled on alpha-melanocyte-stimulating hormone, a naturally occurring signaling peptide involved in pigmentation. Its structure is a cyclic heptapeptide containing two non-natural substitutions, norleucine at position four and D-phenylalanine at position seven. These modifications resist enzymatic breakdown and extend the molecule's activity relative to the native hormone. The compound binds melanocortin receptors and is studied mainly as a pharmacological tool rather than a therapeutic product. It has never received approval as a medicine in any major jurisdiction.
Independent verification is central to quality control because the compound is not produced under pharmaceutical manufacturing standards. Third-party laboratories can measure purity, identity, residual solvents, and microbial contamination, though the scope of testing varies between services. Reported analyses of vendor samples have shown batch-to-batch variation in peptide content and the presence of truncated or oxidized species. How much of this variation reflects synthesis conditions versus storage and shipping is not well characterized. No harmonized reference standard exists for the material as sold.
Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.
Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.
== Early life == Watson was educated at Xavier College in Kew. From years five to eight he attended Xavier's Kostka Hall junior campus in Brighton. He played junior football with the East Sandringham Junior Football Club and the Sandringham Dragons in the TAC Cup. His father Tim played 307 games for Essendon from 1977 to 1994, playing in three premierships with the club, and captained Essendon from 1989 to 1991, before coaching St Kilda from 1999 to 2000; he is currently a commentator for the Seven Network.
=== Radiotherapy === Radiotherapy can be integrated with imaging techniques to guide treatment planning, monitor radiation dose distribution, and assess treatment response. Molecular imaging methods, such as PET and SPECT, can be employed to visualize and quantify tumor characteristics, such as hypoxia or receptor expression, aiding in personalized radiation dose optimization10. Additionally, theranostic approaches involving radiolabeled therapeutic agents, known as radiotheranostics, combine the therapeutic effects of radiation with diagnostic capabilities. Radiotheranostics, including Peptide receptor radionuclide therapy (PRRT), hold promise for targeted radiotherapy, enabling precise tumor targeting and dose escalation, while sparing healthy tissues. For example, PRRT based on Lutetium-177 combinations (known as radioligands) has emerged as a treatment option for inoperable metastatic neuroendocrine tumours (NET).
=== Post-RDS-1 === In the subsequent years it became increasingly valuable to gather information on the Soviet nuclear weapons program, which resulted in the development of technologies that could gather airborne particles in a WB-29 weather reconnaissance plane. On September 3, 1949, these particles were used to determine that the detonation time of the first Soviet atomic test, "Joe 1". Further analysis revealed that this bomb was a replicate of the "Fat Man", which was the bomb dropped on Nagasaki in 1945. This investigative methodology combined radiochemistry and other techniques to gather intelligence on nuclear activities. During the 1961 Soviet nuclear tests, most of the Novaya Zemlya shots were likely monitored by RB-47 aircraft flown from RAF Brize Norton and elsewhere. In August, Khrushchev had announced the existence 100 megaton Soviet bomb, ultimately tested as the Tsar Bomba. A JKC-135A was rapidly outfitted to monitor the test, under Operation Speed Light Bravo. Photomutiplier detectors in UV, visibile, and near-IR were used, with multiplication factors above 100 million. Cine and stills cameras were used, with lens resolutions up to 70 mm. One side of the aircraft was scorched. It has been argued that if the Tsar Bomba had been configured to yield 100 megatons instead of the decided 50, that the aircraft would have been destroyed. The United Kingdom worked with the US to monitor Soviet tests. RAF debris collection missions flew from the summer of 1949 from Scotland, Northern Ireland, and Gibraltar, filling the North Atlantic.
==== Elimination ==== The drug exhibits non-linear pharmacokinetics. Upon multiple dosing, the accumulation of ritonavir is lower than predicted from a single dose, which is possibly due to a time- and dose-related increase in drug clearance. The circulating half-life of ritonavir is typically 3 to 5 hours. Elimination occurs primarily via the feces (86.4 ± 2.9%, with 33.8 ± 10.8% excreted as unchanged parent drug), while a smaller fraction is excreted in the urine (11.3 ± 2.8%, with 3.5 ± 1.8% as unchanged parent drug).
Sources: en.wikipedia.org
The nature of the organic group on the silanization agent strongly influences the properties of the surface. Simple alkyl-containing silanizing groups confer hydrophobicity. When side chains of the silane compound are amines or thiols, the surfaces assume the properties of those functional groups. These surfaces are susceptible to further reactions characteristic of the appended functional groups. Grafting can be performed, for example.
Pharmaceutical formulation, in pharmaceutics, is the process in which the active drug or Active Pharmaceutical Ingredient (API) is combined with different chemical substances to produce a final medicinal product. The word formulation is often used in a way that includes dosage form.
== Cleaning == Like all protein-based fibers (wool, silk), products made from vicuña wool must be cleaned by dry cleaning (water-free) or by hand in tepid water with a mild detergent. Detergents which contain bleach or enzymes (protein-degrading enzymes) are unsuitable, as they damage the hair structure. In the case of hydrophilic textiles, such as textiles made of wool, water contact can lead to thread shortening and thus to shrinkage of the textile due to swelling and the shrinkage that follows during drying. Shrinkage is intensified in clothes dryers. Due to a tendency to felting, textiles made of vicuña wool should not be wrung or rubbed, but can be dabbed.
=== Courier services === There are a large number of local and international courier companies operating in South Africa, delivering documents and parcels on-demand for individuals and commercial entities. These companies provide services such as domestic and international delivery, cross-border e-commerce logistics, customs clearance, freight forwarding, warehousing, distribution, and last-mile parcel delivery. Courier companies operating in SA include:
=== Sarah Braverman-Holt === Sarah Tracey Braverman (Lauren Graham), age 38 at the beginning of the series, is the second child and oldest daughter. She and her two children (Amber and Drew) move back into her parents' house in the pilot episode because of her financial situation. At the show's beginning, it is established that she had previously worked as a bartender for over ten years and as a graphic artist for local bands, including her ex-husband's. She is divorced from her rocker husband Seth (John Corbett), who appears to have been a very poor father figure to their children due to his drug use, alcoholism, and touring schedule. They were married for 12 years. After she fails to obtain a job with a design company due to her lack of a college degree, Sarah once again takes a bartending job. However, she soon begins an internship position at the same company where her older brother, Adam, works. She starts dating her boss despite her brother's disapproval. However, she eventually leaves him when she finds out that he sold the company without the knowledge of its employees. One night, she writes a play which her father passes to his friend, who is well-connected in Broadway. Her play is later produced. She turns 40 in the third season, which means she had her 17-year-old daughter, Amber, when she was 23 and Drew when she was 25. Sarah rekindles her relationship with Mark Cyr, who is 12 years her junior, after revealing to Amber that she is falling in love with him.
Sources: en.wikipedia.org
=== Measurement === Several techniques are used to measure hemoglobin A1c. Laboratories may use high-performance liquid chromatography, immunoassay, enzymatic assay, capillary electrophoresis, or boronate affinity chromatography. Point of care (e.g., doctor's office) devices use immunoassay boronate affinity chromatography. In the United States, HbA1c testing laboratories are certified by the National Glycohemoglobin Standardization Program to standardize them against the results of the 1993 Diabetes Control and Complications Trial (DCCT). An additional percentage scale, Mono S has previously been in use by Sweden and KO500 is in use in Japan.
These techniques can be highly multiplexed for simultaneous quantification of many targets (panels of up to 38 markers) in single cells. Antibody-DNA quantification: another antibody-based method converts protein levels to DNA levels. The conversion to DNA makes it possible to amplify protein levels and use NGS to quantify proteins. In one such approach, two antibodies are selected for each protein needed to be quantified. The two antibodies are then modified to have single stranded DNA connected to them that are complementary. When the two antibodies bind to a protein the complementary strands will anneal and produce a double stranded segment of DNA that can then be amplified using PCR. Each pair of antibodies designed for one protein is tagged with a different DNA sequence. The DNA amplified from PCR can then be sequenced, and the protein levels quantified.
U.S. patent 1,126,605 Refrigerating apparatus U.S. patent 1,222,170 Refrigerating apparatus The History of the Refrigerator and Freezers Archived 31 May 2020 at the Wayback Machine Refrigerators, Canada Science and Technology Museum "Walking fridge, comes when you call it". Engadget. September 2017. Retrieved 8 March 2022.
Viserys I Targaryen is a fictional character in American author George R. R. Martin's the A Song of Ice and Fire series of epic fantasy novels, appearing in the 2013 novella The Princess and the Queen, the 2014 novella The Rogue Prince and the 2018 novel Fire & Blood. In the HBO television adaptation House of the Dragon, he is portrayed by English actor Paddy Considine. Viserys was the fifth king from the Targaryen dynasty to sit on the Iron Throne, ruling from 103 AC to 129 AC. He inherited the throne from his grandfather Jaehaerys I Targaryen, who had lost several previous heirs of his own issue. He is the older brother of Prince Daemon Targaryen, husband of queens Aemma Arryn and Alicent Hightower, and father of Queen Rhaenyra Targaryen and King Aegon II Targaryen. Ruling in a peacetime period, Viserys remained open-minded and approachable in addressing problems across the realm, and many lords and smallfolk praised him for his generosity. He hosted many tournaments, balls, and banquets in the Red Keep, a source of both unity and division depending on the occasion. He was not very physically active like Daemon, and dealt with various health problems that continued to worsen towards the end of his reign. The issue of succession caused much friction in Viserys' court, as he struggled to stabilize relations between the green faction led by Alicent and black faction led by Rhaenyra.
Familial benign unconjugated hyperbilirubinaemia Constitutional liver dysfunction Familial non-hemolytic non-obstructive jaundice Icterus intermittens juvenilis Low-grade chronic hyperbilirubinemia Unconjugated benign bilirubinemia
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide modelled on alpha-melanocyte-stimulating hormone. A lactam bridge links two side chains, forming a ring that stabilises the molecule against proteolysis. It belongs to the broader melanocortin peptide family.
No national medicines agency has approved melanotan-2 for clinical use. Afamelanotide, a related but distinct peptide, holds a marketing authorisation in the European Union for a rare photosensitivity disorder. Melanotan-2 itself is handled as a laboratory chemical.
Its broad activity across melanocortin receptors makes it a tool for probing pigmentation, appetite and vascular signalling. Early trials recorded skin darkening and other effects that were not the original focus of the work. Those observations generated hypotheses that later studies have examined.
The lyophilised solid is best kept cold, dry and dark, typically at minus twenty degrees Celsius. Moisture and repeated warming cycles are the main causes of degradation. Solutions prepared from the powder are less stable and are normally used quickly.